Every 10-Q that Legacy Education Inc (LGCY) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow LGCY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LGCY filings page.
Legacy Education Inc. reported higher revenue and earnings for the quarter and nine months ended March 31, 2026. Tuition and related income reached $21.4M for the quarter and $60.0M for the nine months, up from $18.6M and $46.2M a year earlier.
Net income rose to $3.0M for the quarter and $7.3M for the nine months, compared with $2.8M and $6.3M previously. Basic earnings per share were $0.24 for the quarter and $0.58 year-to-date. The company ended the period with $21.7M in cash and cash equivalents and total assets of $75.5M, while total liabilities declined to $25.9M, supporting growth in stockholders’ equity.
Legacy Education Inc. reported strong growth for the three months ended December 31, 2025. Tuition and related revenue rose to $19.2 million from $13.6 million a year earlier, driven by higher enrollment and program activity across its healthcare and technical schools.
Operating income increased to $2.6 million from $1.7 million, while net income improved to $2.0 million from $1.4 million. For the six-month period, revenue reached $38.6 million versus $27.6 million, and net income grew to $4.2 million from $3.5 million, showing solid profitability.
The balance sheet remained conservative, with cash and cash equivalents of $21.1 million, total assets of $73.1 million, and stockholders’ equity of $46.1 million as of December 31, 2025. Debt was modest, and the company’s composite score with the U.S. Department of Education was disclosed as 3.0, indicating strong financial responsibility.
Legacy Education Inc. (LGCY) reported Q1 FY2026 results for the three months ended September 30, 2025. Revenue was $19,401,023, up from $14,005,091 a year ago, driven by higher tuition and related fees. Operating income was $2,698,650 versus $2,672,276, and net income was $2,186,960 compared with $2,090,753. Diluted EPS was $0.16 (basic $0.18) versus $0.21 (basic $0.22) last year.
Cash and cash equivalents were $20,586,087. Total assets were $72,090,408, liabilities $28,424,787, and stockholders’ equity $43,665,621. Operating cash flow was $1,056,335, reflecting higher accounts receivable as enrollment and billings expanded.
The company continues to integrate its December 2024 acquisition of Contra Costa Medical Career College and remains focused on accredited, career-focused programs across its institutions. Shares outstanding were 12,566,988 as of November 10, 2025.